Modulight Biotherapeutics
United States
- Boston, Massachusetts
- 13/11/2025
- Seed
- $12,000,000
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
- Industry Biotechnology Research
- Website https://www.modulight.bio/
- LinkedIn https://www.linkedin.com/company/modulight-bio/
Related People
Yotam EldarFounder
United States -
Boston, Massachusetts
Experienced leader of operational and technology teams, with a passion for solving complex multidisciplinary problems in a data-driven and results-oriented manner, to achieve a solid and positive impact in the world.
Long track record of excellence across several fields and industries - from leading complex special operations and projects, through medical practice, to biotech innovation.
Currently Yotam is focused on building a transformative solution for intractable neurological conditions, utilizing his deep technical understanding, creativity, leadership and networking skills to create a truly meaningful, positive change for patients.
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)